Sort
8,912 grants matching “sars cov 2”
Molecular mechanisms of sex difference in COVID-19 enabling novel therapeutics
$155,866Hua Linda Cai · University Of California Los Angeles · R01 · FY2022 · HL
CT and CXR Phenotyping Platform for Assessing COVID-19 Susceptibility and Severity
$155,730Raul San Jose Estepar · Brigham And Women'S Hospital · R21 · FY2021 · LM
Northern New England Clinical and Translational Research Network-Equipment
$155,705Clifford J Rosen · Mainehealth · U54 · FY2023 · GM
Surveillance for the Spread of COVID-19 Variants through South Dakota
$155,569Barbara E Goodman · University Of South Dakota · P20 · FY2021 · GM
SARS-COV-2 Environmental Constraint Effects on Cancer Prevention and Management Outcomes
$155,500Richard D Schulick · University Of Colorado Denver · P30 · FY2020 · CA
Evaluating Efficacy of Antiseptic Mouth Rinses on Salivary SARS-CoV-2 Infectivity
$155,500Laura Anne Jacox · Univ Of North Carolina Chapel Hill · R03 · FY2022 · DE
Evaluating Efficacy of Antiseptic Mouth Rinses on Salivary SARS-CoV-2 Infectivity
$155,500Laura Anne Jacox · Univ Of North Carolina Chapel Hill · R03 · FY2023 · DE
Pharmacology Shared Resource
$155,500Dan Theodorescu · University Of Colorado Denver · P30 · FY2020 · CA
Boosting T-cell immunity against COVID19 after CAR T-cell therapy by vaccination
$155,500Richard D Schulick · University Of Colorado Denver · P30 · FY2020 · CA
Ultra-Sensitive Combined Antigen and Serology Rapid Test for COVID-19
$155,412Michael Barry Kastan · Duke University · P30 · FY2020 · CA
A PORTABLE MULTI-MODAL OPTICO-IMPEDANCE SYTEM FOR EARLY WARNING OF PROGRESSION IN STABLE COVID-19 PATIENTS
$155,282Ryan Joseph Halter · Multivariate Systems, Inc. · R41 · FY2021 · EB
Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases
$155,251H. Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Biochemical Strategy to Avert Microbial Drug Resistance
$155,100Ronald T Raines · Massachusetts Institute Of Technology · R21 · FY2023 · AI
Analysis of clinical trial data to better understand Long Covid
$155,000Carolyn T Bramante · University Of Minnesota · R03 · FY2025 · TR
Psychosocial Stress due to COVID-19 and Vascular Aging in African-American Women
$154,880Tenã T Lewis · Emory University · R01 · FY2024 · HL
Understanding the Molecular Genetic Mechanisms of Asthma Risk Loci: IL33, IL1RL1, and GSDMB - COVID 19 Supplement
$154,778Erin D. Gordon · University Of California, San Francisco · R01 · FY2021 · AI
Novel animal models to dissect how lung macrophages contribute to SARS-CoV2 alveolar pathology and respiratory failure
$154,777David W Gludish · Cornell University · K01 · FY2022 · OD
Developing newly combined therapeutic strategies for mature B cell lymphoma
$154,751Jing Hong Wang · University Of Colorado Denver · R01 · FY2020 · CA
Assessment of SARS-Coronavirus-2 Levels and Genetics in Vivo
$154,746Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Appalachian Node
$154,576Jane M Liebschutz · University Of Pittsburgh At Pittsburgh · UG1 · FY2021 · DA
The role of serotonin signaling in the nucleus accumbens in excessive alcohol drinking
$154,500Catherine Anne Marcinkiewcz · University Of Iowa · R00 · FY2020 · AA
Building Trust to Enhance Diversity in Aging Research
$154,498C. Daniel Mullins · University Of Maryland Baltimore · R24 · FY2021 · AG
RAPID: Developing a novel biosensor for rapid, direct and selective detection of COVID-19 using DNA aptamer-nanopore
$154,457Yi Lu · University Of Illinois At Urbana-Champaign · · FY2020 · ENG
A Randomized Controlled Clinical Trial of the Neuroimmune Modulator Ibudilast for the Treatment of Alcohol Use Disorder
$154,440Lara Ray · University Of California Los Angeles · R01 · FY2021 · AA
Role of SARS-CoV-2 Spike Protein and Accessory ORFs in the immune pathogenesis of COVID-19
$154,304John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI